Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...

The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for ...

We may have been late compared to Novo Nordisk and Eli Lilly, but as it is ... and are noted for having muscle loss as a major drawback during weight loss. They show a weight loss effect of ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

Westhill 67, Skaneateles 53: The Lakers were outscored by 12 points in the fourth quarter Wednesday in a road loss. Jack ...

Reaching Super Bowl 59, seven Philadelphia Eagles defenders, including their past three first round draft picks, played Florida high school football.

Hanmi Pharmaceutical Senior Vice President Choi In-young, head of the ... market currently led by Eli Lilly and Novo Nordisk with its own diverse range of weight-loss treatments tailored to ...

When the final matches concluded, four GC Grapplers had earned “All County” honors, with one wrestler claiming a Nassau ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Eli Lilly (NYSE: LLY) sells a broad variety of drugs across treatment areas, but one particular portfolio has driven growth in recent times -- and this is likely to continue. I'm talking about Lilly's ...

From Novo Holding's purchase of Catalent to BMS's Karuna acquisition, here are 10 of the most significant M&A moments of 2024 ...